APA (7th ed.) Citation

Eyre, T. A., Phillips, E. H., Linton, K. M., Arumainathan, A., Kassam, S., Gibb, A., . . . Collins, G. P. (2017). Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting. British Journal of Haematology, 179(3), 471. https://doi.org/10.1111/bjh.14898

Chicago Style (17th ed.) Citation

Eyre, Toby A., et al. "Results of a Multicentre UK-wide Retrospective Study Evaluating the Efficacy of Brentuximab Vedotin in Relapsed, Refractory Classical Hodgkin Lymphoma in the Transplant Naive Setting." British Journal of Haematology 179, no. 3 (2017): 471. https://doi.org/10.1111/bjh.14898.

MLA (9th ed.) Citation

Eyre, Toby A., et al. "Results of a Multicentre UK-wide Retrospective Study Evaluating the Efficacy of Brentuximab Vedotin in Relapsed, Refractory Classical Hodgkin Lymphoma in the Transplant Naive Setting." British Journal of Haematology, vol. 179, no. 3, 2017, p. 471, https://doi.org/10.1111/bjh.14898.